| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |